Baculovirus vector with long-acting stable expression and construction method thereof
A construction method and recombinant baculovirus technology, applied in the field of baculovirus vector construction, can solve the problems of limited clinical application scope, limited expression level and expression time, and achieve stable expression, improved expression time and expression level. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0059] Example 1 The construction method and functional verification of the baculovirus vector capable of long-term and stable expression
[0060] (1) Construction of recombinant plasmids
[0061] 1. Construction of pBacSC-CE plasmid
[0062] Design primers SC-F / SC-R to amplify the SC fragment from the plasmid PUC57-SC (preserved in this laboratory, that is, transfer the SC fragment shown in SEQID NO.1 into the PUC57 plasmid), namely GP64 SP-His6- MCS-GP64 TM-GP64 CTD expression element, then insert the element into plasmid pFastBac TM In the corresponding site downstream of the DUAL (Invitrogen) p10 promoter, a CMV-EGFP fragment was inserted downstream of the plasmid pPh promoter, and the fragment was obtained by double enzyme digestion from the plasmid pEGFP-C1 (Clontech). The correct plasmid identified by PCR and sequencing was named pBacSC-CE.
[0063] The relevant primer sequences, restriction sites, amplified fragments and sizes are shown in Table 1, and the identific...
Embodiment 2
[0098] Example 2 Preliminary application of baculovirus vector capable of long-term and stable expression in anti-angiogenic gene therapy of liver cancer
[0099] Considering that the development and metastasis of primary tumors critically rely on the formation of new blood vessels to provide oxygen and nutrients. Therefore, inhibiting angiogenesis has become a very attractive anticancer strategy. The fusion protein (hEA) composed of human endostatin (Endostatin) and angiostatin (angiostatin) showed greater anti-angiogenic activity and stronger anti-tumor efficiency in animal tumor models. In view of this, the present invention uses a long-acting, stably expressed baculovirus vector as a platform to construct a recombinant baculovirus expressing hEA protein, and evaluates its function and anti-tumor effect against liver cancer tumors. It is characterized in that comprising the steps of:
[0100] (1) Construction of recombinant baculovirus expressing hEA protein
[0101] 1. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


